ACT-777991

N/A

Report date: 2024/06/05 15:56:09
NME

Base Information

Drug NameACT-777991
Drug Alias NameACT-777991
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 3 antagonists
TargetsC-X-C motif chemokine receptor 3
Therapy Area/IndicationsInflammationDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsSwitzerland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIdorsia Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIdorsia Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsInflammationDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A